Skip to main content
. Author manuscript; available in PMC: 2017 Jul 25.
Published in final edited form as: Leuk Lymphoma. 2012 Dec 5;54(7):1411–1417. doi: 10.3109/10428194.2012.745525

Table 1.

Patient demographics and incidence of chronic myeloid leukemia in1975–2009

Characteristic No. of patients Incidence per 100,000 (95% CI) Relative risk (95% CI)
Age, years
Median 66
Range 0–108
<15 175 0.09(0.08–0.11)
15–29 720 0.35(0.33–0.38) 3.8(3.2–4.5)
30–49 2,514 1.03(0.99–1.07) 11.1(9.5–13.0)
50–64 2,965 2.33(2.25–2.42) 25.1(21.6–29.5)
65–74 2,944 5.53(5.33–5.73) 59.6(51.1–69.8)
>75 7,495 7.88(7.70–8.06) 84.9(73.1–99.3)
Total 13869 1.75(1.72–1.78)
Sex
Female 5,928 1.34(1.31–1.38)
Male 7,941 2.32(2.27–2.37) 1.7(1.7–1.8)
Race
Other* 809 1.19(1.11–1.28)
Caucasian 11,720 1.78(1.75–1.81) 1.5(1.4–1.6)
African American 1,234 1.77(1.67–1.87) 1.5(1.4–1.6)
unknown 106
Calendar year of diagnosis
1975–1989 5,001 1.78(1.73–1.83)
1990–2000 4,719 1.81(1.76–1.86) 1.0(1.0–1.1)
2001–2009 4,149 1.67(1.62–1.72) 0.9(0.9–1.0)
Registry
Hawaii 531 1.44(1.32–1.57)
Atlanta (Metropolitan) 945 1.49(1.39–1.59) 1.0(0.9–1.1)
San Francisco-Oakland SMSA 2,004 1.59(1.52–1.66) 1.1(1.0–1.2)
Connecticut 1,849 1.57(1.50–1.65) 1.1(1.0–1.2)
Utah 816 1.66(1.55–1.78) 1.2(1.0–1.3)
New Mexico 839 1.69(1.58–1.81) 1.2(1.0–1.3)
Seattle (Puget Sound) 2,060 1.84(1.76–1.93) 1.3(1.2–1.4)
Iowa 2,069 1.91(1.83–2.00) 1.3(1.2–1.5)
Detroit (Metropolitan) 2,756 2.13(2.05–2.21) 1.5(1.3–1.6)
*

American Indian/Alaska Native and Asians/Pacific populations